FDA — authorised 8 December 1995
- Application: NDA020221
- Marketing authorisation holder: COSETTE
- Status: supplemented
FDA authorised Ethyol on 8 December 1995 · 804 US adverse-event reports
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
Yes. FDA authorised it on 8 December 1995; FDA has authorised it.
COSETTE holds the US marketing authorisation.